Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Garau

Showing results (131-140 of 156) with videos related to

Pageof 16
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 21, 2010
Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection controlY Carmeli, M Akova, G Cornaglia, et al.
International Journal of Oral and Maxillofacial Surgery|January 19, 2007
Prophylaxis versus pre-emptive treatment for infective and inflammatory complications of surgical third molar removal: a randomized, double-blind, placebo-controlled, clinical trial with sustained release amoxicillin/clavulanic acid (1000/62.5 mg)J M Lacasa, J A Jiménez, V Ferrás, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|December 1, 1994
[Hip prosthesis infection: diagnostic approach and treatment of 27 cases]M Salavert, J Martínez, C Sánchez, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 18, 2008
Risk factors for opportunistic infections in infliximab-treated patients: the importance of screening in preventionC Garcia-Vidal, S Rodríguez-Fernández, S Teijón, et al.
Antimicrobial Agents and Chemotherapy|October 30, 1999
Emergence and dissemination of quinolone-resistant Escherichia coli in the communityJ Garau, M Xercavins, M Rodríguez-Carballeira, et al.
The Journal of Infectious Diseases|November 1, 1993
Ciprofloxacin and trimethoprim-sulfamethoxazole versus placebo in acute uncomplicated Salmonella enteritis: a double-blind trialC Sánchez, E García-Restoy, J Garau, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1986
Imipenem in the treatment of severe bacterial infections in seriously ill patientsJ Garau, R Martín, E Bouza, et al.
The European Respiratory Journal|April 24, 2009
Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective studyC Garcia-Vidal, P Almagro, V Romaní, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 3, 2010
Low-dose beta-lactam plus amikacin in febrile neutropenia: cefepime vs. piperacillin/tazobactam, a randomized trialL Gómez, C Estrada, I Gómez, et al.
The American Journal of Gastroenterology|February 3, 1998
Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healingM Forné, J M Viver, M Esteve, et al.
Pageof 16

Showing results (131-140 of 156) with videos related to

Sort By:
Pageof 16
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 21, 2010
Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection controlY Carmeli, M Akova, G Cornaglia, et al.
International Journal of Oral and Maxillofacial Surgery|January 19, 2007
Prophylaxis versus pre-emptive treatment for infective and inflammatory complications of surgical third molar removal: a randomized, double-blind, placebo-controlled, clinical trial with sustained release amoxicillin/clavulanic acid (1000/62.5 mg)J M Lacasa, J A Jiménez, V Ferrás, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|December 1, 1994
[Hip prosthesis infection: diagnostic approach and treatment of 27 cases]M Salavert, J Martínez, C Sánchez, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 18, 2008
Risk factors for opportunistic infections in infliximab-treated patients: the importance of screening in preventionC Garcia-Vidal, S Rodríguez-Fernández, S Teijón, et al.
Antimicrobial Agents and Chemotherapy|October 30, 1999
Emergence and dissemination of quinolone-resistant Escherichia coli in the communityJ Garau, M Xercavins, M Rodríguez-Carballeira, et al.
The Journal of Infectious Diseases|November 1, 1993
Ciprofloxacin and trimethoprim-sulfamethoxazole versus placebo in acute uncomplicated Salmonella enteritis: a double-blind trialC Sánchez, E García-Restoy, J Garau, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1986
Imipenem in the treatment of severe bacterial infections in seriously ill patientsJ Garau, R Martín, E Bouza, et al.
The European Respiratory Journal|April 24, 2009
Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective studyC Garcia-Vidal, P Almagro, V Romaní, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 3, 2010
Low-dose beta-lactam plus amikacin in febrile neutropenia: cefepime vs. piperacillin/tazobactam, a randomized trialL Gómez, C Estrada, I Gómez, et al.
The American Journal of Gastroenterology|February 3, 1998
Randomized clinical trial comparing two one-week triple-therapy regimens for the eradication of Helicobacter pylori infection and duodenal ulcer healingM Forné, J M Viver, M Esteve, et al.
Pageof 16